The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $124,993,937.09 cost-sharing definitive contract to Ossium Health, Inc., a for-profit biotechnology company, to develop a bone marrow cryogenic banking capability to treat acute radiation syndrome in a mass casualty emergency. The contract has an ultimate completion date of July 31, 2029 and was not set aside for any specific business type. Ossium Health has received over $2.6 million in previous federal grants from the National Institutes of Health to support research on stem cell transplantation, cell manufacturing, and medical countermeasures for radiation injury.
Generated 8/21/24, 7:11 PM